Deciphera Pharmaceuticals (DCPH) Misses Q2 EPS by 6c

August 3, 2021 4:42 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q2 EPS of ($1.21), $0.06 worse than the analyst estimate of ($1.15). Revenue for the quarter came in at $22 million versus the consensus estimate of $22 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities